Clinical Trials Logo

Cerebrospinal Fluid Leak clinical trials

View clinical trials related to Cerebrospinal Fluid Leak.

Filter by:

NCT ID: NCT04505423 Completed - Clinical trials for Cerebrospinal Fluid Drainage

Evaluation of Outcomes Related to Cerebrospinal Fluid Drain Placement

Start date: August 3, 2020
Phase:
Study type: Observational

The purpose of this study is to compare the rate and severity of complications associated with CSFD placement either with or without fluoroscopic guidance.

NCT ID: NCT04503161 Withdrawn - CSF Leak Clinical Trials

The Effect of an ASC-seeded Collagen Hydrogel on Cerebrospinal Fluid Leak Rates Following Skull Base Surgery

Start date: September 2021
Phase: N/A
Study type: Interventional

This project seeks to test whether a cell-seeded collagen hydrogel dressing can reduce CSF leak after skull base surgery. Normally, patients at risk for CSF leak are treated with a commercial collagen matrix called Duragen. In this study, our sterile, cGMP manufactured collagen hydrogel dressing will be seeded with the stromal vascular fraction (SVF) mechanically isolated from lipoaspirate taken intra-operatively. This SVF contains pro-regenerative adipose stem cells (ASCs). The ASC-seeded hydrogel will be used as a supplement to Duragen to reinforce the skull base closure. The goal is to establish safety as well as to secondarily evaluate for effectiveness in reducing CSF leak postoperatively.

NCT ID: NCT04490629 Recruiting - Clinical trials for Cerebrospinal Fluid Leak

The Efficacy and Safety of a Latest Dural Substitute

ESLO
Start date: November 1, 2019
Phase: N/A
Study type: Interventional

This prospective, multi-center, randomized, parallel-controlled clinical trial was designed to evaluate the efficacy and safety of Lyoplant Onlay in repairing cerebral dura mater. DURAFORM was regarded as the control group. a total of 80 patients were randomized into experimental and control group (1:1).Data were collected on complications resulting in CSF leaks, surgical site infections, instrument performance parameterized other neurological complications within 30 days. Surgeons also provided data on the ease of use of the dural sealing techniques, as well as preparation and application times. The above-mentioned date were used to evaluate the efficacy and safety of Lyoplant Onlay .

NCT ID: NCT04351061 Withdrawn - Clinical trials for Cerebrospinal Fluid Leak

Acetazolamide for the Prevention of Post Operative CSF Leak

Start date: May 7, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this research is to test the use of Acetazolamide in preventing post-operative cerebrospinal fluid leak in patients having endoscopic skull base surgery (it is a surgery performed through the nose and sinus).

NCT ID: NCT04145544 Completed - Clinical trials for Cerebrospinal Fluid Leak

A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair.

NEOART
Start date: January 7, 2020
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the safety and effectiveness of ArtiFascia® in comparison with commercially available dural substitutes in patients requiring Dural repair following neurosurgery. Patients with planned cranial neurosurgery can take part in this study. During the surgery the soft membrane that covers the brain (called dura) is likely to be cut and damaged. A damaged dura can cause a leakage of brain fluids (cerebrospinal fluid [CSF] leakage) and increase the risk of infections. Sponsor of this study has developed the ArtiFascia®. ArtiFascia® is a medical synthetic dural substitute that is absorbed by the body. ArtiFascia® supports the re-formation of a new dura. In addition it has a sealant layer that can reduce CSF leakage and infection.

NCT ID: NCT04124523 Completed - Clinical trials for Cerebrospinal Fluid Leak

Perioperative CSF Leak Management - an Opinion Study

Start date: January 1, 2019
Phase:
Study type: Observational

Cerebrospinal fluid (CSF) leak is a rare condition. When it involves the ventral skull base, a surgical closure may be achieved using endoscopic skull base surgery techniques. The major principles remain in achieving a watertight closure that can also support the brain (and avoid brain sagging) in case of extensive skull base defects. Surgical techniques are well described. Many clinical factors may influence the successful rate of the reconstruction. However, there is a lack of clinical study on perioperative management of CSF leaks. The purpose of this study is to gather the opinion of skull base surgeons on the post-operative management of patients to avoid CSF leak recurrence. •Methods: The investigators will collect data from skull base surgeons using an electronic survey questionnaire (Google Form, Google, Mountain View, California, U.S.A.) submitted by e-mail to the members of the French Association of Rhinology, to the European Rhinologic Society, to the French college of neurosurgeons, to the Italian skull base society members, and to the former students of the European endoscopic skull base diploma. This is an anonymous 60-items survey. Questions were classified in eight sections: general questions, material used at the end of the surgical procedure, post-operative resting position, drugs, CSF depletion, post-operative advices, explorations in case of early recurrence of the rhinorrhoea, and follow-up modalities. •Discussion: The investigators aim to understand the actual practice of skull base surgeons after closure of ventral skull base CSF leaks. This can serve as a basis for conducting clinical studies in the future.

NCT ID: NCT04086550 Recruiting - Clinical trials for Cerebrospinal Fluid Leak

Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery

ENCASE-II
Start date: May 20, 2021
Phase: N/A
Study type: Interventional

The objective of the study is to clinically assess the safety and effectiveness of LIQOSEAL® as a means of reducing intra- as well as post-operative CSF leakage in patients undergoing elective cranial intradural surgery with a dural closure procedure to show noninferiority compared to a control group.

NCT ID: NCT04057157 Completed - Clinical trials for Cerebrospinal Fluid Leak

Post-market Assessment of Biodesign Dural Repair Grafts

Start date: September 3, 2019
Phase:
Study type: Observational

The purpose of this clinical study is to gather post-market clinical evidence on the use of the Biodesign® Dural and Duraplasty Grafts when used as a dura substitute of the dura mater.

NCT ID: NCT03566602 Completed - Clinical trials for Cerebrospinal Fluid Leak

Evaluate the Safety and Performance of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery

Start date: October 11, 2018
Phase: N/A
Study type: Interventional

The objective of the study is to clinically assess the safety and performance of the Dura Sealant Patch as a means of reducing intra- as well as post-operative CSF leakage in patients undergoing elective cranial intradural surgery with a dural closure procedure.

NCT ID: NCT03545984 Completed - Clinical trials for Cerebrospinal Fluid Drainage Catheter

Evaluation of a Simulation Based Workshop in an Anesthesia Residency Program

Start date: June 5, 2014
Phase: N/A
Study type: Interventional

The study aim is to determine whether simulation based learning would improve senior anesthesiology residents' patient care performance during the insertion and management of cerebrospinal fluid drainage catheters when compared to interactive problem based learning (PBL) using the Anesthetist's Nontechnical Skills Global rating scale